Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 4716       

   Table of Contents      
CORRESPONDENCE
Year : 2011  |  Volume : 133  |  Issue : 3  |  Page : 341-342

Anti-nucleosome antibody in sclerodema patients


1 Evangelic University Hospital Medicine Department, Clinical Hospital, Federal University of Paraná, Curitiba, Paraná, Brazil
2 Evangelic University Hospital Medicine Department, Clinical Hospital, Federal University of Paraná, Curitiba, Paraná;Laboratory of Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Paraná, Brazil
3 Laboratory of Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Paraná, Brazil

Date of Web Publication6-Apr-2011

Correspondence Address:
Thelma Larocca Skare
Rua Joăo Alencar Guimarăes, 796, 80310 420 Curitiba PR
Brazil
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21441692

Rights and PermissionsRights and Permissions

How to cite this article:
de Araújo FM, Skare TL, Nisihara RM, Utiyama SR. Anti-nucleosome antibody in sclerodema patients. Indian J Med Res 2011;133:341-2

How to cite this URL:
de Araújo FM, Skare TL, Nisihara RM, Utiyama SR. Anti-nucleosome antibody in sclerodema patients. Indian J Med Res [serial online] 2011 [cited 2020 Mar 28];133:341-2. Available from: http://www.ijmr.org.in/text.asp?2011/133/3/341/78391

Sir,

Nucleosomes are considered to be the basic element of chromatin. These are formed by 200 ± 40 base pairs segment of DNA wrapped around the (H2A-H2B,H3-H4) 2 histone octamer with histone H1 bound on the outside 1[] . These may become immunogenic, triggering the production of autoantibodies under particular conditions such as presence of drug interactions or infections [1] .

Even though nucleosomes are considered to be the main antigens in the pathophysiology of systemic lupus erythematosus (SLE), some investigators have also found these in systemic sclerosis (SSc). This finding has been an interesting point of discussion because of the discrepancies in results. Wallace et al[1] observed high frequencies of these autoantibodies in scleroderma patients with limited and diffuse form of this disease. Amoura et al[2] detected these in 45.9 per cent of 37 scleroderma patients and Quattrocchi et al[3] in 36.3 per cent of 11 patients. On the other hand, Hmida et al[4] studying 49 SSc patients found only one positive patient similar to Cervera et al[5] who showed one positive in 10 SSc patients. These discrepancies have been attributed to different detection methods used. Binding of anti-Scl-70 to chromatin [6] and the patient's ethnic background may also account for these differences.

We studied anti-nucleosome antibodies in 54 consecutive SSc patients in a cross-sectional study at Evangelic University Hospital, Parana, Brazil during February to December 2009 was approved by the local Ethical Research Committee. All 54 investigated patients fulfilled the American College of Rheumatology (ACR) preliminary criteria for SSc [7] . In this group, 40 (74%) had limited form, 10 (18.6%) had generalized and 4 (7.4%) had PM-SSc (scleroderma-polimyositis) form. Patients with lupus mixed features (n=2) were excluded. Four patients were males and 50 female with mean age of 49.2 ± 12.7 yr. Interstitial lung disease was documented in 17 of 52 (32.7%). Anti-Scl-70 antibodies were found in 7 patients (13.4%).

After written consent, blood (5 ml) was collected from each patient. Samples were centrifuged for 10 min at 10000 g and serum separated, aliquoted and stored at -80 o C until used. The detection of anti-nucleosome antibodies was done by ELISA using nucleosomes extracted from calf thymus chromatin as antigen (Inova Diagnostics Inc, USA). The cut-off point was of 20.0 U/ml, in accordance with manufacturer instructions. Data were analyzed through frequency tables and contingency tables using χ2 and Fisher tests with help of the software Graph Pad Prism, version 4.0 and adopting significance of 5 per cent.

Of the 54 patients tested, five (9.2%) were anti-nucleosome positive. Of these five, one was with PM-SSc form and four with limited form and none in the diffuse form. Values ranged between 36 to 151 UI/ml (mean 67 ± 38.8). No association was found between the presence anti-nucleosome antibodies and lung fibrosis or with presence of Scl-70.

In conclusion, our findings show that scleroderma should be considered a possibility while searching for the exact diagnosis of a connective tissue disease in a patient positive for anti-nucleosome antibodies. More research will be necessary to clarify the role of finding these autoantibodies in SSc.

Conflict of interest: The authors have declared no conflict of interest.

 
   References Top

1.Wallace DJ, Lin HC, Shen GQ, Peter JB. Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double stranded DNA or to H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum 1994; 37 : 1795-7.   Back to cited text no. 1
[PUBMED]    
2.Amoura Z, Piette JC, Bach JF, Koutouzov S. The key role of nucleosome in lupus. Arthritis Rheum 1999; 42 : 833-43.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  
3.Quattrocchi F, Barrile A, Bonanno D, Giannetto L, Patafi M, Tigano M, et al. The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases. Reumatismo 2005; 57 : 109-13.  Back to cited text no. 3
    
4.Hmida YBH, Schmidt P, Gilson G, Humbel R-L. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum 2002; 46 : 280-2.  Back to cited text no. 4
    
5.Cervera R, Vinas O, Ramos-Casals M, Font J, Garcia-Carrasco M, Siso A, et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003; 62 : 431-4.  Back to cited text no. 5
    
6.Koutouzov S, Jeronimo AL, Campos H, Amoura Z. Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 2004: 30 : 529-58.  Back to cited text no. 6
    
7.Hudson M, Taillefer S, Steele R, Dunne J, Johnson SR, Jones N, et al . Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25 : 754-7.  Back to cited text no. 7
[PUBMED]  [FULLTEXT]  




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed725    
    Printed44    
    Emailed0    
    PDF Downloaded142    
    Comments [Add]    

Recommend this journal